Adocia (ADOCY)
11.80
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Adocia Debt to Equity Ratio: -0.8315 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.8315 |
| June 30, 2023 | -1.166 |
| December 31, 2022 | 0.00 |
| June 30, 2022 | -6.839 |
| December 31, 2021 | 0.00 |
| June 30, 2021 | -6.641 |
| December 31, 2020 | 0.00 |
| June 30, 2020 | 1.252 |
| December 31, 2019 | 0.00 |
| June 30, 2019 | 0.2466 |
| December 31, 2018 | 0.00 |
| June 30, 2018 | 0.1639 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2017 | 0.1371 |
| December 31, 2016 | 0.00 |
| June 30, 2016 | 0.1296 |
| December 31, 2015 | 0.0168 |
| June 30, 2015 | 0.0323 |
| December 31, 2014 | 0.9186 |
| June 30, 2014 | 0.1627 |
| December 31, 2013 | 0.1168 |
| June 30, 2013 | 0.1107 |
| December 31, 2012 | 0.106 |
| June 30, 2012 | 0.00 |
| December 31, 2011 | 0.5664 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-6.839
Minimum
Jun 2022
1.252
Maximum
Jun 2020
-1.398
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 0.3968 |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 0.9462 |
| Innate Pharma SA | 0.7525 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 27.59M |
| Total Liabilities (Quarterly) | 35.23M |
| Shareholders Equity (Quarterly) | -7.642M |
| Current Ratio | 1.020 |
| Net Debt Paydown Yield | 5.02% |